Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNABW) Return on Equity (2021 - 2025)

Historic Return on Equity for Ginkgo Bioworks Holdings (DNABW) over the last 5 years, with Q3 2025 value amounting to 0.58%.

  • Ginkgo Bioworks Holdings' Return on Equity rose 2200.0% to 0.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.6% for FY2024, which is 300.0% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Return on Equity stood at 0.58% for Q3 2025, which was up 2200.0% from 0.5% recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Return on Equity high stood at 0.28% for Q3 2021, and its period low was 2.35% during Q3 2022.
  • For the 5-year period, Ginkgo Bioworks Holdings' Return on Equity averaged around 0.93%, with its median value being 0.79% (2023).
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Return on Equity plummeted by -20600bps in 2022 and then skyrocketed by 17300bps in 2023.
  • Ginkgo Bioworks Holdings' Return on Equity (Quarter) stood at 1.15% in 2021, then dropped by -15bps to 1.32% in 2022, then skyrocketed by 43bps to 0.76% in 2023, then increased by 5bps to 0.72% in 2024, then grew by 20bps to 0.58% in 2025.
  • Its Return on Equity stands at 0.58% for Q3 2025, versus 0.5% for Q2 2025 and 0.69% for Q1 2025.